PD Dr. Jörg Distler

Medizinische Fakultät Professur für Molekulare Mechanismen der Organfibrose

DEVELOPING A SCREENING TOOL FOR THE DETECTION OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS:THE ILD-RISC RISK SCORE (2022) Bruni C, Tofani L, Fretheim H, Liem S, Velauthapillai A, Bjorkekjaer J, Barua I, et al. Conference contribution TEMPORAL MIGRATION OF IMMUNE CELLS FROM PSORIATIC SKIN TO JOINTS INITIATING SYNOVIAL INFLAMMATION IN PSORIATIC ARTHRITIS (2022) Raimondo MG, Rauber S, Xu C, Mohammadian H, Vogg M, Anchang CG, Rigau A, et al. Conference contribution DERSIMELAGON, A NOVEL ORAL MELANOCORTIN 1 RECEPTOR AGONIST, DEMONSTRATES DISEASE-MODIFYING EFFECTS IN PRECLINICAL MODELS OF SYSTEMIC SCLEROSIS (2022) Kondo M, Suzuki T, Kawano Y, Kojima S, Miyashiro M, Matsumoto A, Kania G, et al. Journal article BIOPHYSICAL PROPERTIES OF MONOCYTES INDICATE DISEASE ACTIVITY, SEVERITY OF FIBROTIC OR MICROVASCULAR MANIFESTATIONS AND THE RISK FOR PROGRESSION IN SYSTEMIC SCLEROSIS (2022) Matei AE, Marketa K, Xu L, Györfi AH, Boxberger E, Soteriou D, Papava M, et al. Conference contribution, Abstract of a poster O-GLCNACYLATION ON NUP153 REGULATES THE EARLY STAGES OF OSTEOCLASTOGENESIS THROUGH MYC NUCLEAR TRANSLOCATION (2022) Li Y, Chen CW, Trinh MT, Honglin Z, Hubel P, Pfannstiel J, Schett G, Distler J Conference contribution THE NUCLEAR RECEPTOR TR4 ORCHESTRATES CYTOSKELETAL ORGANIZATION IN A G alpha 12/ROCK-DEPENDENT MANNER TO PROMOTE MYOFIBROBLAST DIFFERENTIATION AND TISSUE FIBROSIS IN SYSTEMIC SCLEROSIS (2022) Shen L, Zhang Y, Honglin Z, Distler J Conference contribution DEREGULATION OF TFAM EXPRESSION PROMOTES MITOCHONDRIAL DAMAGE AND FIBROBLAST ACTIVATION IN SYSTEMIC SCLEROSIS (2022) Zhou X, Trinh MT, TRAN MANH C, Giessl A, Bergmann C, Györfi AH, Schett G, Distler J Conference contribution ASSESSMENT OF SYSTEMIC SCLEROSIS RELATED MYOCARDIAL FIBROSIS BY 68GA-FAPI-04 PET/CT (2022) Treutlein C, Schmidkonz C, Tascilar K, Chenguiti Fakhouri S, Dees C, Györfi AH, Matei AE, et al. Conference contribution, Abstract of a poster Impaired Mitochondrial Transcription Factor A Expression Promotes Mitochondrial Damage to Drive Fibroblast Activation and Fibrosis in Systemic Sclerosis (2022) Zhou X, Trinh MT, TRAN MANH C, Gießl A, Bergmann C, Györfi AH, Schett G, Distler J Journal article Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment (2022) Bruni C, Heidenreich S, Duenas A, Hoffmann-Vold AM, Gabrielli A, Allanore Y, Chatelus E, et al. Journal article